SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) announced today that the Group for Innovative Cancer Treatment Division of the National Cancer Center in Japan has expanded its clinical research in colorectal cancer using the Hyperion™ Imaging System to study regulatory T (Treg) cell proliferation in tumor tissue with the goal of discovering a novel target for immunotherapy. Globally, colorectal cancer […]

New design for improved clone selection as well as media and feed optimization in fed‑batch and perfusion mimic conditions System supports Cell & Gene therapy applications, including HEK293 for viral vector production, T-cells, iPSCs and other immune-derived cell lines Official launch at the ESACT Conference in Copenhagen (May 5–8, 2019) GOETTINGEN, Germany and ROYSTON, UK –  Sartorius […]

SigNature® T Traceability System to be Installed in Egypt to Tag Two Cotton Varietals STONY BROOK, N.Y. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based manufacturing for product authenticity and traceability solutions, announced today it received an order for the implementation of its SigNature® T cotton traceability system in Egypt to […]

Organ-on-Chip specialist CN Bio has signed a distribution agreement with Sydney-based AXT Pty. Ltd., Australia’s leading supplier of high technology scientific equipment. The agreement will see AXT distribute CN Bio’s innovative bioengineering products to medical researchers in academia and industry throughout Australia, New Zealand and the South Pacific region. CN Bio is a leading lab-on-a-chip company, based in […]

Evidence Street® issues review supporting Whole Genome Sequencing The Blue Cross Blue Shield Association (BCBSA) technology review organization, known as Evidence Street®, issued a positive review of Whole Genome Sequencing (WGS) for children with multiple unexplained congenital anomalies or neurodevelopmental disorders of unknown etiology, as well as rapid WGS for critically-ill infants with suspected genetic disorders. […]

StemoniX and NCATS to explore the use of microBrain® 3D in advancing new treatments for pain, opioid misuse and addiction as part of the NIH HEAL Initiative MAPLE GROVE, MN – StemoniX® Inc., a biotech company revolutionizing how new medicines are discovered, announced that it entered into a Research Collaboration Agreement with the National Center for Advancing Translational […]

NK-92® Cell Based Bioanalytical Solutions are the Key to Optimizing R&D and Commercial Product Development Efforts for Monoclonal Antibodies, Bi-Specifics and Related Biological Products SAN DIEGO–Brink Biologics, Inc., a NantKwest, Inc. (Nasdaq:NK) affiliate who serves as exclusively-licensed distributor of NantKwest’s proprietary NK-92® natural killer cells, offers a variety of research grade aNK™ and haNK® cell lines for […]

Amendment allows for the development of IVD test kits compatible with Illumina technology TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its IVD Test Developmentand Component Supply Agreement with Illumina, Inc. (Illumina), previously amended in June 2017, to enable the expansion of potential fields for […]

Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development SANTA CLARA, Calif., & BOULDER, Colo. Agilent Technologies Inc. (NYSE: A) and SomaLogic, Inc. (a privately held biotechnology company) today announced a multi-year supply agreement whereby Agilent will supply customized high-fidelity oligo microarrays for […]

Nottingham, UK – 30th April 2019 – NanoFCM Co., Ltd. today announced that it has established a new facility to support existing and potential users of its Nano-Flow Cytometry platform. The Centre of Excellence is located in Medicity, a biotech incubator in Nottingham, UK. It will allow a close interaction with the European scientific community, as […]